{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Lactose+Monohydrate+Powder", "query": { "intervention": "Lactose Monohydrate Powder" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 26, "total_pages": 3, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Lactose+Monohydrate+Powder&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-06T07:16:09.193Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03227445", "title": "Comparative Study of ELLIPTA Dry Powder Inhaler (DPI) Versus DISKUS DPI Used With HandiHaler DPI in Subjects With Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "ELLIPTA placebo DPI", "type": "DEVICE" }, { "name": "DISKUS placebo DPI", "type": "DEVICE" }, { "name": "HandiHaler placebo DPI", "type": "DEVICE" }, { "name": "Inhaler preference questionnaires", "type": "OTHER" } ], "intervention_types": [ "DEVICE", "OTHER" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 240, "start_date": "2017-09-20", "completion_date": "2018-01-04", "has_results": true, "last_update_posted_date": "2020-07-08", "last_synced_at": "2026-09-06T07:16:09.193Z", "location_count": 18, "location_summary": "Orlando, Florida • Natchitoches, Louisiana • Saint Charles, Missouri + 14 more", "locations": [ { "city": "Orlando", "state": "Florida" }, { "city": "Natchitoches", "state": "Louisiana" }, { "city": "Saint Charles", "state": "Missouri" }, { "city": "Charlotte", "state": "North Carolina" }, { "city": "Gastonia", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT03227445" }, { "nct_id": "NCT02799784", "title": "An Efficacy Study of Umeclidinium/Vilanterol With Tiotropium/Olodaterol in COPD Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "UMEC/VI", "type": "DRUG" }, { "name": "TIO/OLO", "type": "DRUG" }, { "name": "Albuterol/salbutamol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 236, "start_date": "2016-07-14", "completion_date": "2017-04-27", "has_results": true, "last_update_posted_date": "2018-07-02", "last_synced_at": "2026-09-06T07:16:09.193Z", "location_count": 9, "location_summary": "Clearwater, Florida • Orlando, Florida • St Louis, Missouri + 6 more", "locations": [ { "city": "Clearwater", "state": "Florida" }, { "city": "Orlando", "state": "Florida" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Medford", "state": "Oregon" }, { "city": "Charleston", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02799784" }, { "nct_id": "NCT03705793", "title": "Effectiveness of Mometasone Nasal Irrigation for Chronic Rhinosinusitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Chronic Rhinosinusitis (Diagnosis)", "Allergic Rhinosinusitis", "Chronic Eosinophilic Rhinosinusitis" ], "interventions": [ { "name": "Mometasone Furoate Nasal Irrigation", "type": "DRUG" }, { "name": "Mometasone Nasal Spray", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Washington University School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 53, "start_date": "2019-01-01", "completion_date": "2020-03-15", "has_results": true, "last_update_posted_date": "2025-06-26", "last_synced_at": "2026-09-06T07:16:09.193Z", "location_count": 2, "location_summary": "St Louis, Missouri", "locations": [ { "city": "St Louis", "state": "Missouri" }, { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT03705793" }, { "nct_id": "NCT02794480", "title": "Phase IV Study in Asthma Subjects for Dry Powder Inhaler (DPI) Versus (vs) Metered Dose Inhaler (MDI) Correct Use", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "ELLIPTA DPI", "type": "DEVICE" }, { "name": "GSK MDI", "type": "DEVICE" }, { "name": "AZ MDI", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 324, "start_date": "2016-08-22", "completion_date": "2016-12-15", "has_results": true, "last_update_posted_date": "2019-07-02", "last_synced_at": "2026-09-06T07:16:09.193Z", "location_count": 20, "location_summary": "Huntington Beach, California • Aventura, Florida • Clearwater, Florida + 17 more", "locations": [ { "city": "Huntington Beach", "state": "California" }, { "city": "Aventura", "state": "Florida" }, { "city": "Clearwater", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT02794480" }, { "nct_id": "NCT01848340", "title": "An Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK1265744 Administered as a Single Oral Dose and a Study to Describe the Pharmacokinetics of a Supratherapeutic Dose of GSK1265744 in Healthy Adult Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "HIV-associated Lipodystrophy Syndrome" ], "interventions": [ { "name": "GSK1265744B (sodium salt) containing 14C-GSK1265744B", "type": "DRUG" }, { "name": "150 mg GSK1265744B", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "ViiV Healthcare", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 16, "start_date": "2013-05", "completion_date": "2013-07", "has_results": false, "last_update_posted_date": "2013-11-04", "last_synced_at": "2026-09-06T07:16:09.193Z", "location_count": 1, "location_summary": "Overland Park, Kansas", "locations": [ { "city": "Overland Park", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01848340" }, { "nct_id": "NCT02696850", "title": "The Impact Of The Addition Of Budesonide To Low-Pressure, High-Volume Saline Sinus Irrigation For Chronic Rhinosinusitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Rhinosinusitis", "Chronic Eosinophilic Rhinosinusitis", "Allergic Rhinosinusitis" ], "interventions": [ { "name": "Budesonide", "type": "DRUG" }, { "name": "Saline alone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Washington University School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 80, "start_date": "2016-01-01", "completion_date": "2017-04-13", "has_results": true, "last_update_posted_date": "2019-09-03", "last_synced_at": "2026-09-06T07:16:09.193Z", "location_count": 1, "location_summary": "St Louis, Missouri", "locations": [ { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT02696850" }, { "nct_id": "NCT03012061", "title": "Phase IIb Study of Umeclidinium (UMEC) Bromide Versus Placebo in Subjects With Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "UMEC", "type": "DRUG" }, { "name": "Fluticasone Furoate", "type": "DRUG" }, { "name": "Albuterol/salbutamol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 425, "start_date": "2017-01-25", "completion_date": "2018-05-30", "has_results": true, "last_update_posted_date": "2020-10-28", "last_synced_at": "2026-09-06T07:16:09.193Z", "location_count": 19, "location_summary": "Tempe, Arizona • Rolling Hills Estates, California • Colorado Springs, Colorado + 15 more", "locations": [ { "city": "Tempe", "state": "Arizona" }, { "city": "Rolling Hills Estates", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" }, { "city": "Topeka", "state": "Kansas" }, { "city": "Natchitoches", "state": "Louisiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT03012061" }, { "nct_id": "NCT02141854", "title": "Efficacy and Safety Study of FP MDPI Compared With FS MDPI in Adolescent and Adult Patients With Persistent Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "FS MDPI", "type": "DRUG" }, { "name": "Fp MDPI", "type": "DRUG" }, { "name": "Placebo MDPI", "type": "DRUG" }, { "name": "Albuterol/salmeterol HFA MDI", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teva Branded Pharmaceutical Products R&D, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 882, "start_date": "2014-06", "completion_date": "2015-09", "has_results": true, "last_update_posted_date": "2021-11-09", "last_synced_at": "2026-09-06T07:16:09.193Z", "location_count": 85, "location_summary": "Birmingham, Alabama • Little Rock, Alaska • Phoenix, Arizona + 74 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Little Rock", "state": "Alaska" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Costa Mesa", "state": "California" }, { "city": "Encinitas", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02141854" }, { "nct_id": "NCT01772368", "title": "Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Fp MDPI", "type": "DRUG" }, { "name": "FS MDPI", "type": "DRUG" }, { "name": "Advair Diskus", "type": "DRUG" }, { "name": "Albuterol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teva Branded Pharmaceutical Products R&D, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 72, "start_date": "2013-01", "completion_date": "2013-06", "has_results": true, "last_update_posted_date": "2017-06-12", "last_synced_at": "2026-09-06T07:16:09.193Z", "location_count": 10, "location_summary": "Denver, Colorado • North Dartmouth, Massachusetts • St Louis, Missouri + 7 more", "locations": [ { "city": "Denver", "state": "Colorado" }, { "city": "North Dartmouth", "state": "Massachusetts" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Skillman", "state": "New Jersey" }, { "city": "Raleigh", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01772368" }, { "nct_id": "NCT01113034", "title": "A Safety Trial of DAS181 (Fludase®) in Adult Subjects With Well-Controlled Asthma or Bronchiectasis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Asthma", "Bronchiectasis" ], "interventions": [ { "name": "DAS181 dry powder, formulation F02", "type": "DRUG" }, { "name": "Respitose ML006 (DMV-Fonterra)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Ansun Biopharma, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 11, "start_date": "2010-07", "completion_date": "2011-08-22", "has_results": false, "last_update_posted_date": "2019-03-27", "last_synced_at": "2026-09-06T07:16:09.193Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT01113034" } ] }